Clinical Trial Update: Impact of iv Dexamethasone on Reversal of Rocuronium-induced Neuromuscular Block by Sugammadex [Phase 4]

View source ↗

Summary

A Phase 4 trial evaluating whether intravenous dexamethasone influences reversal of rocuronium-induced neuromuscular blockade with sugammadex has been withdrawn…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Neuromuscular Blockade

Drugs mentioned

• DEXAMETHASONE (Dexamethasone)
• Rocuronium (rocuronium bromide)
• Sugammadex (sugammadex)

Snippet

Sponsor: Centre Hospitalier Universitaire Vaudois | Conditions: Neuromuscular Blockade | Phase 4 | Status: WITHDRAWN